Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
US FDA Observation
|
Strong Performer, Under Radar
872.2000
-9.40
(
-1.07
%)
NSE
Jun 20, 2025
13:56 PM
46.78% Fall from 52W High
Volume:
446.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
05 Dec 2022
US FDA Observation
872.20
-1.07%
NATCO PHARMA
Buy:
Natco Pharma Ltd.
by
Geojit BNP Paribas
Target: 704
Recommendation
Target
Geojit BNP Paribas
Geojit BNP Paribas increased Hold price target of Natco Pharma Ltd. to 952.0 on 11 Jun, 2025.
More from Natco Pharma Ltd.
Recommended
Market trades higher, Nestle to consider bonus issue in a board meeting on June 26
Trendlyne Marketwatch |
20 Jun 2025, 01:37PM
Winners and losers of 2025 in global indices | Screener: Nifty outperformers (so far) this year
The Baseline |
19 Jun 2025, 11:24AM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020, 06:25PM